MSI1 and neoplasm: We observed that around 5% of non-recurrent pancreatic samples exhibited MSI1 in the cytosol (1/18 cases; data not shown) while 60% of recurrent PDAC samples (37/61 cases) displayed cytosolic MSI1 (Figure 8D), suggesting that cytosolic MSI1 was associated with tumor recurrence.